Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration: Implications for the pathogenesis of ethanol-related colorectal cancer

Chronic ethanol consumption is a risk factor for colorectal cancer, and ethanol-induced reactive oxygen species have been suggested to play important roles in the pathogenesis of ethanol-related colorectal cancer (ER-CRC). In this study, the effects of 10-week chronic administration of ethanol on the colonic levels of oxidative stress and advance glycation end product (AGE) levels, as well as fecal microbiota structures, were examined in a mouse model. Chronic oral administration of ethanol in mice (1.0 mL of 1.5% or 5.0% ethanol (v/v) per day per mouse, up to 10 weeks) resulted in the elevation of colonic levels of oxidative stress markers (such as 8-hydroxy-2'-deoxyguanosine and 4-hydroxynonenal) compared to control mice, and this was consistently accompanied by elevated levels of inflammation-associated cytokines and immune cells (Th17 and macrophages) and a decreased level of regulatory T (Treg) cells to produce colonic lesions. It also resulted in an alteration of mouse fecal microbiota structures, reminiscent of the alterations observed in human inflammatory bowel disease, and this appeared to be consistent with the proposed sustained generation of oxidative stress in the colonic environment during chronic ethanol consumption. Moreover, the first experimental evidence that chronic ethanol administration results in elevated levels of advanced glycation end products (AGEs) and their receptors (RAGE) in the colonic tissues in mice is also shown, implying enhanced RAGE-mediated signaling with chronic ethanol administration. The RAGE-mediated signaling pathway has thus far been implicated as a link between the accumulation of AGEs and the development of many types of chronic colitis and cancers. Thus, enhancement of this pathway likely exacerbates the ethanol-induced inflammatory states of colonic tissues and might at least partly contribute to the pathogenesis of ER-CRC.

[1]  F. A. Moura,et al.  Close interplay of nitro-oxidative stress, advanced glycation end products and inflammation in inflammatory bowel diseases. , 2020, Current medicinal chemistry.

[2]  A. Höhn,et al.  Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications , 2019, Current pharmaceutical design.

[3]  R. Lord,et al.  Colonic lesion characterization in inflammatory bowel disease: A systematic review and meta-analysis , 2018, World journal of gastroenterology.

[4]  F. Bishehsari,et al.  Colorectal Cancer and Alcohol Consumption—Populations to Molecules , 2018, Cancers.

[5]  H. Na,et al.  Molecular Basis of Alcohol-Related Gastric and Colon Cancer , 2017, International journal of molecular sciences.

[6]  A. Papavassiliou,et al.  Potential of glycative stress targeting for cancer prevention. , 2017, Cancer letters.

[7]  A. Yokoyama,et al.  Screening by Total Colonoscopy Following Fecal Immunochemical Tests and Determinants of Colorectal Neoplasia in Japanese Men With Alcohol Dependence , 2016, Alcohol and alcoholism.

[8]  M. Hattori,et al.  Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer , 2016, Scientific Reports.

[9]  P. Korkolopoulou,et al.  Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis , 2016, BMC Cancer.

[10]  H. Bartsch,et al.  The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts , 2014, Redox biology.

[11]  D. Pardoll,et al.  Treg functional stability and its responsiveness to the microenvironment , 2014, Immunological reviews.

[12]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[13]  T. Arisawa,et al.  Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease , 2013, PloS one.

[14]  J. Petrosino,et al.  Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment , 2013, PloS one.

[15]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[16]  K. Dorko,et al.  Melatonin Expresses Powerful Anti-inflammatory and Antioxidant Activities Resulting in Complete Improvement of Acetic-Acid-Induced Colitis in Rats , 2011, Digestive Diseases and Sciences.

[17]  A. Mantovani,et al.  Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer , 2010, Oncogene.

[18]  V. Purohit,et al.  Molecular mechanisms of alcoholic fatty liver. , 2009, Alcoholism: Clinical and Experimental Research.

[19]  E. Lakatta,et al.  RAGE signaling in inflammation and arterial aging. , 2009, Frontiers in bioscience.

[20]  K. Matsuo,et al.  Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. , 2008, American journal of epidemiology.

[21]  F. Stickel,et al.  “Allgemeine und systematische Pharmakologie und Toxikologie” WS 18/19 Seminarthema: Chemische Kanzerogenese , 2017 .

[22]  S. Das,et al.  Alcohol-induced oxidative stress. , 2007, Life sciences.

[23]  M. Andrassy,et al.  Posttranslationally modified proteins as mediators of sustained intestinal inflammation. , 2006, The American journal of pathology.

[24]  Defeng Wu,et al.  Alcohol, Oxidative Stress, and Free Radical Damage , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[25]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[26]  M. Shih,et al.  Dose‐dependent effects of chronic ethanol on mouse adipose tissue lipase activity and cyclic AMP accumulation , 1997, British journal of pharmacology.

[27]  Paul J Thornalley Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy. , 1996, General pharmacology.

[28]  J. Wallace,et al.  Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. , 1995, The American journal of physiology.

[29]  M. Brownlee,et al.  Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.

[30]  R. Russell,et al.  Enhancement of ethanol induced rectal mucosal hyper regeneration with age in F344 rats. , 1994, Gut.

[31]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[32]  R. Bucala,et al.  Lipid advanced glycosylation: pathway for lipid oxidation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Namiki Chemistry of Maillard reactions: recent studies on the browning reaction mechanism and the development of antioxidants and mutagens. , 1988, Advances in food research.

[34]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[35]  E. Mezey,et al.  Distribution of ethanol in the human gastrointestinal tract. , 1973, The American journal of clinical nutrition.